These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 30618357

  • 1. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
    Atkin W, Cross AJ, Kralj-Hans I, MacRae E, Piggott C, Pearson S, Wooldrage K, Brown J, Lucas F, Prendergast A, Marchevsky N, Patel B, Pack K, Howe R, Skrobanski H, Kerrison R, Swart N, Snowball J, Duffy SW, Morris S, von Wagner C, Halloran S.
    Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
    [Abstract] [Full Text] [Related]

  • 2. Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study.
    Cross AJ, Wooldrage K, Robbins EC, Kralj-Hans I, MacRae E, Piggott C, Stenson I, Prendergast A, Patel B, Pack K, Howe R, Swart N, Snowball J, Duffy SW, Morris S, von Wagner C, Halloran SP, Atkin WS.
    Gut; 2019 Sep; 68(9):1642-1652. PubMed ID: 30538097
    [Abstract] [Full Text] [Related]

  • 3. Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.
    Grobbee EJ, Wisse PHA, Schreuders EH, van Roon A, van Dam L, Zauber AG, Lansdorp-Vogelaar I, Bramer W, Berhane S, Deeks JJ, Steyerberg EW, van Leerdam ME, Spaander MC, Kuipers EJ.
    Cochrane Database Syst Rev; 2022 Jun 06; 6(6):CD009276. PubMed ID: 35665911
    [Abstract] [Full Text] [Related]

  • 4. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M, Corro Ramos I, Lang S, Luyendijk M, Zaim R, Stirk L, Al M, Armstrong N, Kleijnen J.
    Health Technol Assess; 2017 May 06; 21(33):1-234. PubMed ID: 28643629
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J, Halloran S, Gray A.
    BMJ Open; 2017 Oct 27; 7(10):e017186. PubMed ID: 29079605
    [Abstract] [Full Text] [Related]

  • 6. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH, Grobbee EJ, Nieuwenburg SAV, Kapidzic A, van Roon AHC, van Vuuren AJ, Lansdorp-Vogelaar I, Spijker WWJ, Izelaar K, Bruno MJ, Kuipers EJ, Spaander MCW.
    Lancet Gastroenterol Hepatol; 2019 Aug 27; 4(8):622-631. PubMed ID: 31196734
    [Abstract] [Full Text] [Related]

  • 7. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.
    de Klerk CM, Wieten E, Lansdorp-Vogelaar I, Bossuyt PM, Spaander MC, Dekker E.
    Lancet Gastroenterol Hepatol; 2019 Feb 27; 4(2):111-118. PubMed ID: 30497962
    [Abstract] [Full Text] [Related]

  • 8. One-sample quantitative and two-sample qualitative faecal immunochemical tests for colorectal cancer screening: a cross-sectional study in China.
    Wang L, Chen H, Zhu Y, Lu M, Wang Y, Chen X, Ma W, Du L, Chen W.
    BMJ Open; 2022 May 19; 12(5):e059754. PubMed ID: 35589365
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy.
    Tsapournas G, Hellström PM, Cao Y, Olsson LI.
    Scand J Gastroenterol; 2020 Feb 19; 55(2):184-192. PubMed ID: 31906738
    [Abstract] [Full Text] [Related]

  • 10. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
    Digby J, Cleary S, Gray L, Datt P, Goudie DR, Steele RJC, Strachan JA, Humphries A, Fraser CG, Mowat C.
    United European Gastroenterol J; 2020 Jun 19; 8(5):559-566. PubMed ID: 32213041
    [Abstract] [Full Text] [Related]

  • 11. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
    Cross AJ, Robbins EC, Pack K, Stenson I, Kirby PL, Patel B, Rutter MD, Veitch AM, Saunders BP, Little M, Gray A, Duffy SW, Wooldrage K.
    Health Technol Assess; 2022 May 19; 26(26):1-156. PubMed ID: 35635015
    [Abstract] [Full Text] [Related]

  • 12. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
    Moss S, Mathews C, Day TJ, Smith S, Seaman HE, Snowball J, Halloran SP.
    Gut; 2017 Sep 19; 66(9):1631-1644. PubMed ID: 27267903
    [Abstract] [Full Text] [Related]

  • 13. Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopy.
    Bonello B, Ghanouni A, Bowyer HL, MacRae E, Atkin W, Halloran SP, Wardle J, von Wagner C.
    BMC Gastroenterol; 2016 Sep 13; 16(1):113. PubMed ID: 27618798
    [Abstract] [Full Text] [Related]

  • 14. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.
    Zorzi M, Hassan C, Capodaglio G, Fedato C, Montaguti A, Turrin A, Rosano A, Monetti D, Stocco C, Baracco S, Russo F, Repici A, Rugge M.
    Gut; 2018 Dec 13; 67(12):2124-2130. PubMed ID: 29101260
    [Abstract] [Full Text] [Related]

  • 15. One or two faecal immunochemical tests in an organised population-based colorectal cancer screening programme in Murcia (Spain).
    Tourne-Garcia C, Perez-Riquelme F, Monteagudo-Piqueras O, Fraser CG, Yepes-Garcia P.
    J Med Screen; 2022 Dec 13; 29(4):231-240. PubMed ID: 35578555
    [Abstract] [Full Text] [Related]

  • 16. Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study.
    Lincoln A, Benton S, Piggott C, North BV, Rigney J, Young C, Quirke P, Sasieni P, Monahan KJ.
    BMC Cancer; 2022 Nov 07; 22(1):1144. PubMed ID: 36344941
    [Abstract] [Full Text] [Related]

  • 17. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives.
    Ribbing Wilén H, Blom J, Höijer J, Andersson G, Löwbeer C, Hultcrantz R.
    Scand J Gastroenterol; 2019 Mar 07; 54(3):303-310. PubMed ID: 30907196
    [Abstract] [Full Text] [Related]

  • 18. Head-to-head comparison of the test performance of self-administered qualitative vs. laboratory-based quantitative fecal immunochemical tests in detecting colorectal neoplasm.
    Lu M, Zhang YH, Lu B, Cai J, Liu CC, Chen HD, Dai M.
    Chin Med J (Engl); 2021 May 19; 134(11):1335-1344. PubMed ID: 34039863
    [Abstract] [Full Text] [Related]

  • 19. Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold.
    Young GP, Woodman RJ, Symonds E.
    BMJ Open Gastroenterol; 2020 Sep 19; 7(1):. PubMed ID: 32994195
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
    Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mallant-Hent RC, Lansdorp-Vogelaar I, Bossuyt PMM, Kuipers EJ, Dekker E, Spaander MCW.
    Clin Gastroenterol Hepatol; 2020 Mar 19; 18(3):667-675.e1. PubMed ID: 31419575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.